Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Shares Outstanding (2021 - 2025)

Bioregenx's Shares Outstanding history spans 5 years, with the latest figure at $962.0 million for Q3 2025.

  • Quarterly results put Shares Outstanding at $962.0 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $962.0 million (changed N/A YoY), and the annual figure for FY2024 was $957.0 million, up 25183955.26%.
  • Shares Outstanding for Q4 2025 was $969.0 million at Bioregenx, up from $3800.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $969.0 million in Q4 2025 to a low of $3800.0 in Q4 2022.
  • The 5-year median for Shares Outstanding is $269.7 million (2022), against an average of $434.9 million.
  • The sharpest move saw Shares Outstanding soared 25183955.26% in 2024, then tumbled 100.0% in 2025.
  • Year by year, Shares Outstanding stood at $4.9 million in 2021, then tumbled by 99.92% to $3800.0 in 2022, then changed by 0.0% to $3800.0 in 2023, then soared by 25183955.26% to $957.0 million in 2024, then grew by 0.52% to $962.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $962.0 million, $3800.0, and $960.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.